Advertisement
Screener

Verrica Pharmaceuticals Inc. (VRCA) Form D

Verrica Pharmaceuticals Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2025-12-10: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-11-25; Total offering amount $50,017,383.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2025-12-10Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-11-25$50,017,383$50,017,383$021

Similar stocks

Stock NameCountryMarket CapPE Ratio
OS Therapies Inc (OSTX)United States$0.076B-2.17
iBio, Inc. (IBIO)United States$0.077B-2.94
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40